Anpario Plc (ANP) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Anpario Plc (ANP) has a cash flow conversion efficiency ratio of 0.112x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX4.58 Million ≈ $557.13 USD) by net assets (GBX40.96 Million ≈ $4.98K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Anpario Plc to measure how many days the company can operate on defensive assets alone.
Anpario Plc - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how Anpario Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Anpario Plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Anpario Plc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
LUNGLIFE AI INC. DL-0001
F:9H4
|
N/A |
|
Asian Television Network International Ltd
V:SAT
|
-0.121x |
|
ALPHAHELIX MOL.DIAGN. SK1
F:4MB
|
-2.585x |
|
The Alumasc Group plc
LSE:ALU
|
0.068x |
|
Marksmen Energy Inc
V:MAH
|
-0.009x |
|
Shree Ram Proteins Limited
NSE:SRPL
|
0.071x |
|
1Spatial PLC
LSE:SPA
|
0.062x |
|
Alturas Minerals Corp
V:ALT
|
0.011x |
Annual Cash Flow Conversion Efficiency for Anpario Plc (2002–2025)
The table below shows the annual cash flow conversion efficiency of Anpario Plc from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see ANP stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | GBX40.96 Million ≈ $4.98K |
GBX6.02 Million ≈ $732.82 |
0.147x | -8.67% |
| 2024-12-31 | GBX36.29 Million ≈ $4.42K |
GBX5.84 Million ≈ $710.92 |
0.161x | -37.70% |
| 2023-12-31 | GBX33.65 Million ≈ $4.09K |
GBX8.70 Million ≈ $1.06K |
0.258x | +882.05% |
| 2022-12-31 | GBX41.31 Million ≈ $5.03K |
GBX1.09 Million ≈ $132.26 |
0.026x | -66.28% |
| 2021-12-31 | GBX40.30 Million ≈ $4.90K |
GBX3.15 Million ≈ $382.66 |
0.078x | -49.80% |
| 2020-12-31 | GBX37.51 Million ≈ $4.56K |
GBX5.83 Million ≈ $709.34 |
0.155x | +39.21% |
| 2019-12-31 | GBX35.55 Million ≈ $4.33K |
GBX3.97 Million ≈ $483.03 |
0.112x | +37.65% |
| 2018-12-31 | GBX33.15 Million ≈ $4.03K |
GBX2.69 Million ≈ $327.17 |
0.081x | -52.69% |
| 2017-12-31 | GBX30.52 Million ≈ $3.71K |
GBX5.23 Million ≈ $636.83 |
0.171x | +28.85% |
| 2016-12-31 | GBX28.54 Million ≈ $3.47K |
GBX3.80 Million ≈ $462.11 |
0.133x | +4.24% |
| 2015-12-31 | GBX26.58 Million ≈ $3.23K |
GBX3.39 Million ≈ $412.95 |
0.128x | -10.56% |
| 2014-12-31 | GBX22.75 Million ≈ $2.77K |
GBX3.25 Million ≈ $395.07 |
0.143x | -1.70% |
| 2013-12-31 | GBX20.13 Million ≈ $2.45K |
GBX2.92 Million ≈ $355.64 |
0.145x | +19.68% |
| 2012-12-31 | GBX17.89 Million ≈ $2.18K |
GBX2.17 Million ≈ $264.03 |
0.121x | -3.65% |
| 2011-12-31 | GBX16.00 Million ≈ $1.95K |
GBX2.02 Million ≈ $245.17 |
0.126x | +83.64% |
| 2010-12-31 | GBX14.79 Million ≈ $1.80K |
GBX1.01 Million ≈ $123.37 |
0.069x | -55.15% |
| 2009-12-31 | GBX13.61 Million ≈ $1.66K |
GBX2.08 Million ≈ $253.08 |
0.153x | +166.70% |
| 2008-12-31 | GBX7.54 Million ≈ $916.91 |
GBX432.00K ≈ $52.56 |
0.057x | -37.23% |
| 2007-12-31 | GBX7.13 Million ≈ $867.27 |
GBX651.00K ≈ $79.21 |
0.091x | +137.05% |
| 2006-12-31 | GBX6.76 Million ≈ $822.74 |
GBX-1.67 Million ≈ $-202.83 |
-0.247x | +15.15% |
| 2005-12-31 | GBX1.86 Million ≈ $226.55 |
GBX-541.00K ≈ $-65.82 |
-0.291x | +62.61% |
| 2004-12-31 | GBX619.00K ≈ $75.31 |
GBX-481.00K ≈ $-58.52 |
-0.777x | -109.73% |
| 2003-12-31 | GBX-61.00K ≈ $-7.42 |
GBX-487.00K ≈ $-59.25 |
7.984x | -89.29% |
| 2002-12-31 | GBX-15.00K ≈ $-1.83 |
GBX-1.12 Million ≈ $-136.03 |
74.533x | -- |
About Anpario Plc
Anpario plc, together with its subsidiaries, manufactures and distributes natural animal feed additives for animal health, nutrition, and biosecurity. Its health and performance category offers various products that support and maintain animal gut health, including phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; and feed… Read more